Amgen Inc. buy UBS Group AG
Start price
26.01.26
/
50%
€293.05
Target price
26.01.27
-
Performance (%)
27.98%
Price
15:32
€370.00
Summary
This prediction is currently active. The prediction currently has a performance of 27.98%. A total of €5.04 was paid as dividends for this prediction. This prediction currently runs until 26.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 2.483% | 2.483% |
| iShares Core DAX® | -1.586% | 5.028% |
| iShares Nasdaq 100 | -4.148% | -0.125% |
| iShares Nikkei 225® | -6.302% | 0.528% |
| iShares S&P 500 | -3.225% | 0.470% |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for AMGN provided by MarketBeat